Biotoxtech top shareholder Kang Jong Koo raises stake to 24.30% from 24.29% via open-market buys
Bitget2026/09/23 01:00- Biotoxtech controlling shareholder Kang Jong Koo raised his stake to 3,903,385 shares, or 24.3%, from 3,900,685 shares, or 24.29%.
- The increase followed open-market purchases totaling 2,700 shares, with the reporting obligation triggered on Sept. 16, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Novo Nordisk (NVO.US) considers entering the hair loss market, seeking new growth points with its "post-Wegovy" strategy
Novo Nordisk is targeting the hair loss market, seeking to diversify its drug portfolio.
The growth of the traditional network equipment industry may have peaked! Piper Sandler lowers Cisco (CSCO.US) target price to 125 USD.
Piper Sandler analyst James Fish maintains a "Neutral" rating on Cisco, while lowering the target price from $132 to $125.
Runway Growth Finance director Edward J. Goldthorpe acquires USD 67,253.48 in common shares